Investigation of Immune Biomarkers Using Subcutaneous Model of M. tuberculosis Infection in BALB/c Mice: A Preliminary Report |
Husain, Aliabbas A.
(Biochemistry Research Laboratory, Central India Institute of Medical Sciences)
Daginawala, Hatim F. (Biochemistry Research Laboratory, Central India Institute of Medical Sciences) Warke, Shubangi R. (Department of Veterinary Microbiology and Animal Biotechnology, Nagpur Veterinary College) Kalorey, Devanand R. (Department of Veterinary Microbiology and Animal Biotechnology, Nagpur Veterinary College) Kurkure, Nitin V. (Department of Veterinary Microbiology and Animal Biotechnology, Nagpur Veterinary College) Purohit, Hemant J. (Environmental Genomic Unit, National Environmental Engineering Research Institute (NEERI), CSIR) Taori, Girdhar M. (Biochemistry Research Laboratory, Central India Institute of Medical Sciences) Kashyap, Rajpal S. (Biochemistry Research Laboratory, Central India Institute of Medical Sciences) |
1 | Kashyap, R. S., A. R. Nayak, A. A. Husain, H. M. Gaherwar, H. J. Purohit, G. M. Taori and H. F. Daginawala. 2013. Tuberculosis in India: the continuing challenge. Curr. Sci. 105: 597-606. |
2 | Husain, A. A., R. S. Kashyap, D. R. Kalorey, S. R. Warke, H. J. Purohit, G. M. Taori, and H. F. Daginawala. 2011. Effect of repeat dose of BCG vaccination on humoral response in mice model. Indian J. Exp. Biol. 49: 7-10. |
3 | Parida, S. K., and S. H. Kaufmann. 2010. Novel tuberculosis vaccines on the horizon. Curr. Opin. Immunol. 22: 374-384. DOI |
4 | Hoft, D. F. 2008. Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet 372: 164-175. DOI |
5 | Morais, F. D., R. S. Rosada, M. O. Paula, P. F. Wowk, L. H. Franco, E. G. Soares, C. L. Silva, and V. L. peron Bonato. 2010. Experimental tuberculosis: designing a better model to test vaccines against tuberculosis. Tuberculosis (Edinb.) 90: 135-142. DOI |
6 | Sugawara, I., T. Udagawa, T. Aoki, and S. Mizuno. 2009. Establishment of a guinea pig model of latent tuberculosis with GFP-introduced Mycobacterium tuberculosis. Tohoku J. Exp. Med. 219: 257-262. DOI |
7 | Bonanni, D., L. Rindi, N. Lari, and C. Garzelli. 2005. Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice. J. Med. Microbiol. 54: 443-448. DOI |
8 | Sharpe, S. A., H. McShane, M. J. Dennis, R. J. Basaraba, F. Gleeson, G. Hall, A. McIntyre, K. Gooch, S. Clark, N. E. Beveridge, E. Nuth, A. White, A. Marriott, S. Dowall, A. V. Hill, A. Williams, and P. D. Marsh. 2010. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing. Clin. Vaccine Immunol. 17: 1170-1182. DOI |
9 | Gupta, U. D. and V. M. Katoch. 2009. Animal models of tuberculosis for vaccine development. Indian J. Med. Res. 129: 11-18. |
10 | Flynn, J. L. 2004. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb.) 84: 93-101. DOI |
11 | Shekhawat, S. D., R. K Jain, H. M. Gaherwar, H.J. Purohit, G. M. Taori, H. F. Daginawala, and R. S Kashyap. 2014. Heat shock proteins: possible biomarkers in pulmonary and extrapulmonary tuberculosis. Hum. Immunol. 75: 151-158. DOI |
12 | Ottenhoff, T. H., and S. H. Kaufmann. 2012. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 8: e1002607. DOI |
13 | Kashyap, R. S., A. R. Nayak, S. Gaikwad, R. K. Jain, H. F. Daginawala, and G. M. Taori. 2013. Biomarkers in pulmonary and extra pulmonary tuberculosis. Proceedings of the International conference on Advances in developing Affordable Invitro molecular Diagnostics. p. 73-86. |
14 | Abebe, F., and G. Bjune. 2009. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin. Exp. Immunol. 157: 235-243. DOI |
15 | Zuniga, J., D. Torres-Garcia, T. Santos-Mendoza, T. S. Rodriguez-Reyna, J. Granados, and E. J. Yunis. 2012. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin. Dev. Immunol. 2012: 193923. |
16 | Kozakiewicz, L., Y. Chen, J. Xu, Y. Wang, K. Dunussi-Joannopoulos, Q. Ou, J. L. Flynn, S. A. Porcelli, W. R. Jacobs, Jr., and J. Chan. 2013. B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response. PLoS Pathog. 9: e1003472. DOI |
17 | Acosta, A., M. N. Norazmi, R. Hernandez-Pando, N. Alvarez, R. Borrero, J. F. Infante, and M. E. Sarmiento. 2011. The importance of animal models in tuberculosis vaccine development. Malays. J. Med. Sci. 18: 5-12. |
18 | Fremond, C. M., V. Yeremeev, D. M. Nicolle, M. Jacobs, V. F. Quesniaux, and B. Ryffel. 2004. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 114: 1790-1799. DOI |
19 | Kolibab, K., A. Yang, M. Parra, S. C. Derrick, and S. L. Morris. 2014. Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines. Clin. Vaccine Immunol. 21: 453-455. DOI |
20 | Srivastava, S., A. Ayyagari, T. N. Dhole, N. Krishnani, K. K. Nyati, and S. K. Dwivedi. 2008. Progression of chronic pulmonary tuberculosis in mice intravenously infected with ethambutol resistant Mycobacterium tuberculosis. Indian J. Med. Microbiol. 26: 342-348. DOI |
![]() |